Vascular endothelial growth factor prolongs survival in a transgenic mouse model of ALS

Annals of Neurology
Chengyun ZhengJan-Inge Henter

Abstract

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease associated with the death of motor neurons in the spinal cord and brainstem. The cause of ALS is unknown and there is no cure. This study demonstrates, for the first time, that vascular endothelial growth factor (VEGF) delays progression of symptoms and prolongs survival in a Cu/Zn superoxide dismutase (SOD1) transgenic mouse model of ALS. These observations suggest that VEGF or related compounds, might be of value in the treatment of ALS patients.

References

Sep 14, 2000·Proceedings of the National Academy of Sciences of the United States of America·M L BrinesA Cerami
Sep 23, 2000·Nature·P Carmeliet, R K Jain
Jun 2, 2001·The New England Journal of Medicine·L P Rowland, N A Shneider
Nov 21, 2001·Nature Reviews. Neuroscience·D W Cleveland, J D Rothstein
Mar 19, 2003·Circulation·Timothy D HenryUNKNOWN VIVA Investigators
Mar 26, 2003·Brain Research. Molecular Brain Research·Baolin LiRugao Liu
Jul 5, 2003·Science·Alireza AlaviDavid A Cheresh
Dec 6, 2003·The EMBO Journal·Haruhisa InoueRyosuke Takahashi
Jun 8, 2004·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Panya S ManoonkitiwongsaPatrick D Lyden

❮ Previous
Next ❯

Citations

Apr 5, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·James C DodgeBrian K Kaspar
Sep 23, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·James C DodgeBrian K Kaspar
May 29, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Dan KrakoraMasatoshi Suzuki
Dec 29, 2004·Nature Neuroscience·Christine Vande Velde, Don W Cleveland
Mar 29, 2008·Antioxidants & Redox Signaling·Mauro CozzolinoMaria Teresa Carrì
Oct 14, 2006·Transplantation·Leyan XuVassilis E Koliatsos
Feb 19, 2013·Journal of Neurology, Neurosurgery, and Psychiatry·Mark H B HuismanJan Herman Veldink
Jan 20, 2006·Journal of Neurology, Neurosurgery, and Psychiatry·C MoreauN Just
May 27, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Erica A Dale-NagleGordon S Mitchell
Jan 12, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Yaoming WangKunlin Jin
Dec 25, 2013·Oxidative Medicine and Cellular Longevity·Akshay AnandPawan Kumar Gupta
Jul 6, 2014·BioMed Research International·Ana Catarina Pronto-LaborinhoMamede de Carvalho
Aug 25, 2012·Neurology Research International·Dan KrakoraMasatoshi Suzuki
Feb 7, 2012·Expert Opinion on Investigational Drugs·John A Morren, Nestor Galvez-Jimenez
Sep 14, 2007·Scandinavian Journal of Clinical and Laboratory Investigation·J Iłzecka
Apr 25, 2007·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·Nathan Oates, Roger Pamphlett
Jun 1, 2007·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·Dafang ChenJun Zhang
Aug 26, 2011·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·Michele A KliemNicholas M Boulis
Jan 29, 2013·Journal of the Neurological Sciences·Kazuhiro HigashidaSeiitsu Ono
Jan 31, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·M P ZaninR K Shepherd
Aug 6, 2011·Progress in Neurobiology·Giulietta RiboldiStefania Corti
Jul 21, 2011·Biochemical and Biophysical Research Communications·Ping WangJian-Zhong Bi
Apr 23, 2011·Lancet Neurology·Lorne Zinman, Merit Cudkowicz
Oct 26, 2010·Brain Research Reviews·Thomas W Gould, Ronald W Oppenheim
Oct 21, 2009·Journal of the Neurological Sciences·Michael J Strong
Jul 16, 2008·Physical Medicine and Rehabilitation Clinics of North America·Gregory A Cary, Albert R La Spada
Jul 16, 2008·Physical Medicine and Rehabilitation Clinics of North America·B Jane DistadRobert G Miller
Jul 29, 2008·Neuroscience Research·Sivakumar Sathasivam
Feb 8, 2008·Neurobiology of Disease·Paul S SharpJacqueline de Belleroche
Feb 16, 2007·Neurobiology of Disease·Michael Benatar
Aug 13, 2009·Developmental Neurobiology·J Simon LunnEva L Feldman
Mar 21, 2009·Journal of Neuroscience Research·Seung U Kim, Jean de Vellis
Jul 18, 2009·Muscle & Nerve·Livia PasqualiFrancesco Fornai
Dec 31, 2008·Journal of Neuroscience Research·Cédric Boucherie, Emmanuel Hermans
Apr 4, 2008·Journal of Neurochemistry·Anna-Lena StrömHaining Zhu

❮ Previous
Next ❯

Related Concepts

Related Feeds

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating genetic alterations in this genetically heterogeneous disorder.